{Reference Type}: Journal Article
{Title}: Characteristics of participants who take up screening tests for diabetes and lipid disorders: a systematic review.
{Author}: Ding H;Huang J;Deng Y;Tin SPP;Wong MC;Yeoh EK;
{Journal}: BMJ Open
{Volume}: 12
{Issue}: 4
{Year}: 04 2022 29
{Factor}: 3.006
{DOI}: 10.1136/bmjopen-2021-055764
{Abstract}: To perform a systematic review on the characteristics of participants who attended screening programmes with blood glucose tests, lipid profiles or a combination of them, respectively.
Systematic review following the Meta-analysis Of Observational Studies in Epidemiology checklist.
PubMed and Medline databases for English literature from 1 January 2000 to 1 April 2020.
Original observational studies that reported baseline characteristics of apparently healthy adult participants screening for diabetes and lipid disorders were included in this review.
We examined their sociodemographic characteristics, including age, gender, body mass index (BMI) and lifestyle habits. The quality of the included articles was evaluated by the Appraisal of Cross-sectional Studies.
A total of 33 articles involving 38 studies in 22 countries were included and analysed in this systematic review. Overall, there was a higher participation rate among subjects who were female in all screening modalities (female vs male: 46.6%-63.9% vs 36.1%-53.4% for diabetes screening; 48.8%-58.4% vs 41.6%-51.2% for lipid screening; and 36.4%-76.8% vs 23.2%-63.6% for screening offering both). Compared with the BMI standard from the WHO, participants in lipid screening had lower BMI (male: 23.8 kg/m2 vs 24.2 kg/m2, p<0.01; female: 22.3 kg/m2 vs 23.6 kg/m2, p<0.01). Furthermore, it is less likely for individuals of lower socioeconomic status to participate in diabetes or lipid screening in developed areas.
We identified that individuals from lower socioeconomic groups were less likely to take up programmes for diabetes and/or lipid screening in developed areas. These populations are also likely to be at higher risk of non-communicable diseases. Future studies should investigate the barriers and facilitators of screening among non-participants, where targeted interventions to enhance their screening uptake are warranted.